Association of Lifestyle With Complications in the Diabetic Population

Association of Lifestyle With Complications in the Diabetic Population: a Prospective Study

This study is a prospective study of patients with diabetes. The main objective of this study is to investigate the relationship between lifestyle and long-term complications in diabetic patients, which will help to screen out the high-risk group at an early stage and provide scientific advice for the prevention of complications in diabetic patients.

Study Overview

• Status: Recruiting
• Conditions: Diabetes Mellitus

• Study Type: Observational
• Enrollment (Estimated): 800

Contacts and Locations

• Study Contact: Name: Meng-Chen Zou; Phone Number: +86186 8842 3756; Email: zoumc@smu.edu.cn

Study Locations

• China
  • Guangzhou, China
    • Recruiting
    • Nanfang Hospital of Southern Medical University
    • Contact: Meng-Chen Zou; Phone Number: +86186 8842 3756; Email: zoumc@smu.edu.cn

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: N/A

• Sampling Method: Probability Sample

Study Population

Diabetic patients with or without complications

Description

Inclusion Criteria:

1. Patients with a normative diagnosis of type 2 diabetes
2. Age ≥20 years old, regardless of gender
3. From January 2022 to December 2025, he was treated in Nanfang Hospital

Exclusion Criteria:

1. In the acute infection phase
2. The researchers judged that it was not suitable to participate in this study

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort
Group without complications
Complication group

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Number of Participants with Diabetes Complications	From enrollment to the end of the three-year follow-up

Collaborators and Investigators

• Sponsor: Nanfang Hospital, Southern Medical University

Study record dates

Study Major Dates

• Study Start (Actual): August 1, 2024
• Primary Completion (Estimated): March 30, 2028
• Study Completion (Estimated): March 30, 2028

Study Registration Dates

• First Submitted: March 19, 2025
• First Submitted That Met QC Criteria: March 24, 2025
• First Posted (Actual): March 30, 2025

Study Record Updates

• Last Update Posted (Actual): April 8, 2026
• Last Update Submitted That Met QC Criteria: April 7, 2026
• Last Verified: April 1, 2026

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Endocrine System Diseases; Metabolic Diseases; Glucose Metabolism Disorders; Nutritional and Metabolic Diseases; Diabetes Mellitus
• Other Study ID Numbers: NFEC-2025-067

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No